Cynthia Tuthill

635 total citations
32 papers, 520 citations indexed

About

Cynthia Tuthill is a scholar working on Immunology, Cell Biology and Molecular Biology. According to data from OpenAlex, Cynthia Tuthill has authored 32 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Cell Biology and 9 papers in Molecular Biology. Recurrent topics in Cynthia Tuthill's work include Cellular Mechanics and Interactions (9 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Cynthia Tuthill is often cited by papers focused on Cellular Mechanics and Interactions (9 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Cynthia Tuthill collaborates with scholars based in United States, Italy and Russia. Cynthia Tuthill's co-authors include Guido Rasi, Stephen T. Sonis, Mahnaz Badamchian, Allan L. Goldstein, R. S. B. King, Francesca Pica, Claudia Matteucci, Yinsheng Wan, Brynmor A. Watkins and Wen‐Ming Chu and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

Cynthia Tuthill

32 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cynthia Tuthill United States	17	179	142	105	102	87	32	520
Daniela Ludwig Germany	8	98 0.5×	407 2.9×	80 0.8×	124 1.2×	72 0.8×	15	632
Torunn Løvdal Norway	8	121 0.7×	183 1.3×	106 1.0×	34 0.3×	18 0.2×	8	459
Stephanie Schumacher Germany	11	97 0.5×	319 2.2×	167 1.6×	83 0.8×	25 0.3×	13	664
R S Schulof United States	8	266 1.5×	111 0.8×	44 0.4×	82 0.8×	24 0.3×	14	545
R Suzuki Japan	10	236 1.3×	377 2.7×	23 0.2×	113 1.1×	104 1.2×	16	799
Stanimir S. Ivanov United States	10	517 2.9×	449 3.2×	51 0.5×	136 1.3×	40 0.5×	17	994
Annika Sanfridson United States	10	260 1.5×	251 1.8×	38 0.4×	48 0.5×	35 0.4×	17	710
Mana Miyakoda Japan	16	331 1.8×	307 2.2×	47 0.4×	150 1.5×	26 0.3×	27	742
Julia Tait Lathrop United States	12	91 0.5×	636 4.5×	107 1.0×	49 0.5×	43 0.5×	17	910
Anita Kumari India	11	101 0.6×	104 0.7×	33 0.3×	142 1.4×	45 0.5×	48	477

Countries citing papers authored by Cynthia Tuthill

Since Specialization

Citations

This map shows the geographic impact of Cynthia Tuthill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia Tuthill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia Tuthill more than expected).

Fields of papers citing papers by Cynthia Tuthill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cynthia Tuthill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia Tuthill. The network helps show where Cynthia Tuthill may publish in the future.

Co-authorship network of co-authors of Cynthia Tuthill

This figure shows the co-authorship network connecting the top 25 collaborators of Cynthia Tuthill. A scholar is included among the top collaborators of Cynthia Tuthill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cynthia Tuthill. Cynthia Tuthill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tuthill, Cynthia, et al.. (2016). Immune Modulation with Thymosin Alpha 1 Treatment. Vitamins and hormones. 102. 151–178. 52 indexed citations

King, R. S. B. & Cynthia Tuthill. (2015). Evaluation of thymosin α 1 in nonclinical models of the immune-suppressing indications melanoma and sepsis. Expert Opinion on Biological Therapy. 15(sup1). 41–49. 16 indexed citations

Volk, David E., Cynthia Tuthill, Miguel-Ángel Elizondo-Riojas, & David G. Gorenstein. (2012). NMR structural studies of thymosin α1 and β‐thymosins. Annals of the New York Academy of Sciences. 1270(1). 73–78. 2 indexed citations

Elizondo-Riojas, Miguel-Ángel, Steven M. Chamow, Cynthia Tuthill, David G. Gorenstein, & David E. Volk. (2011). NMR structure of human thymosin alpha-1. Biochemical and Biophysical Research Communications. 416(3-4). 356–361. 21 indexed citations

Alterovitz, Gil, et al.. (2011). Personalized medicine for mucositis: Bayesian networks identify unique gene clusters which predict the response to gamma-d-glutamyl-l-tryptophan (SCV-07) for the attenuation of chemoradiation-induced oral mucositis. Oral Oncology. 47(10). 951–955. 18 indexed citations

Tuthill, Cynthia, et al.. (2010). Thymosin alpha 1: past clinical experience and future promise. Annals of the New York Academy of Sciences. 1194(1). 130–135. 16 indexed citations

Watkins, Brynmor A., Kimberly Pouliot, E G Fey, Cynthia Tuthill, & Stephen T. Sonis. (2010). Attenuation of radiation- and chemoradiation-induced mucositis using gamma-d-glutamyl-l-tryptophan (SCV-07). Oral Diseases. 16(7). 655–660. 22 indexed citations

Tuthill, Cynthia, Shari N. Gordon, Paul J. Pockros, et al.. (2009). 647 TREATMENT OF HEPATITIS C WITH THE IMMUNE- STIMULATING DIPEPTIDE SCV-07. Journal of Hepatology. 50. S238–S238. 2 indexed citations

Nagabhushanam, Vijaya, Krishnaprasad Subbarao, Mohanraj Ramachandran, Jyotsna Reddy, & Cynthia Tuthill. (2008). Inhibition of STAT3 driven gene expression in melanoma cells by SCV-07. Journal of Clinical Oncology. 26(15_suppl). 14619–14619. 1 indexed citations

10.

Tuthill, Cynthia. (2007). Issues in Pharmaceutical Development of Thymosin α1 from Preclinical Studies through Marketing. Annals of the New York Academy of Sciences. 1112(1). 351–356. 5 indexed citations

11.

Tuthill, Cynthia, et al.. (2007). Effect of the immune modulating peptide, SCV-07, in the murine B16 melanoma model. Journal of Clinical Oncology. 25(18_suppl). 13514–13514. 1 indexed citations

12.

Peng, Xiao, Ping Zhang, Xin Wang, et al.. (2007). Signaling Pathways Leading to the Activation of IKK and MAPK by Thymosin α1. Annals of the New York Academy of Sciences. 1112(1). 339–350. 16 indexed citations

13.

Zhang, Ping, Justin Chan, Ana‐Maria Dragoi, et al.. (2005). Activation of IKK by thymosin α1 requires the TRAF6 signalling pathway. EMBO Reports. 6(6). 531–537. 54 indexed citations

14.

Moody, Terry W., Cynthia Tuthill, Mahnaz Badamchian, & Allan L. Goldstein. (2002). Thymosin α1 inhibits mammary carcinogenesis in Fisher rats. Peptides. 23(5). 1011–1014. 22 indexed citations

15.

McCarty, Nael A., T. A. Standaert, M. Teresi, et al.. (2002). A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosis*. Pediatric Pulmonology. 33(2). 90–98. 41 indexed citations

16.

Moody, Terry W., Julius Leyton, Farah Zia, et al.. (2000). Thymosinα1 is chemopreventive for lung adenoma formation in A/J mice. Cancer Letters. 155(2). 121–127. 18 indexed citations

17.

Tuthill, Cynthia, et al.. (2000). Quantitative analysis of thymosin α1 in human serum by LC-MS/MS. AAPS PharmSciTech. 1(2). 37–44. 14 indexed citations

18.

Tuthill, Cynthia, et al.. (2000). Quantitative analysis of thymosin α1 in human serum by LC-MS/MS. AAPS PharmSciTech. 1(2). 37–44. 1 indexed citations

19.

Rasi, Guido, et al.. (2000). Combined treatment with thymosin-α1 and low dose interferon-α after dacarbazine in advanced melanoma. Melanoma Research. 10(2). 189–192. 24 indexed citations

20.

Silecchia, Gianfranço, P Sinibaldi Vallebona, Pasquale Pierimarchi, et al.. (1999). Efficacy of repeated cycles of chemo-immunotherapy with Thymosin α1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery. Cancer Immunology Immunotherapy. 48(4). 172–178. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact